Asia Pacific Biotechnology Market (2008-2012): An Exhaustive View of the Biotechnology Markets in the Asia-Pacific Region.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/65bdec/asia_pacific_biote) has announced the addition of the "Asia Pacific Biotechnology Market (2008-2012)" report to their offering. The report "Asia Pacific Biotechnology Market (2008-2012)" provides an exhaustive view of the biotechnology markets in the Asia-Pacific region (Japan, China, Australia, South Korea, India, Taiwan, New Zealand New Zealand (zē`lənd), island country (2005 est. pop. 4,035,000), 104,454 sq mi (270,534 sq km), in the S Pacific Ocean, over 1,000 mi (1,600 km) SE of Australia. The capital is Wellington; the largest city and leading port is Auckland. and Singapore). It also provides a detailed account of the major factors driving growth in the biotechnology industry of the region and enabling it to become a dominant force in the future. As per our research, countries in the Asia-Pacific region were late starters in the biotechnology market. However, the industry is growing much faster than the industries in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. and Europe, primarily due to low costs, strong government support, large talent pool and biodiversity biodiversity: see biological diversity. biodiversity Quantity of plant and animal species found in a given environment. Sometimes habitat diversity (the variety of places where organisms live) and genetic diversity (the variety of traits expressed . In future both India and China are expected to emerge as leading players in the global biotechnology market. Information on the market size, structure, segmentation, growth, future forecasts, success and risk factors and evolving trends in technology development are thoroughly analyzed an·a·lyze tr.v. an·a·lyzed, an·a·lyz·ing, an·a·lyz·es 1. To examine methodically by separating into parts and studying their interrelations. 2. Chemistry To make a chemical analysis of. 3. in this report. The report also covers the fact that the biotechnology markets in the Asia-Pacific region have huge differences from one another in terms of infrastructure, funding, talent pool, growth, size and potential as an outsourcing (1) Contracting with outside consultants, software houses or service bureaus to perform systems analysis, programming and datacenter operations. Contrast with insourcing. See netsourcing, ASP, SSP and facilities management. destination. Thus, it provides valuable information to pharmaceutical & biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. and investors looking to enter these markets and help them to devise strategies in accordance to the individual markets. Key Findings * Growing at an estimated CAGR CAGR See: Compound Annual Growth Rate of 15.9% between 2005 and 2007, the value of Asia-Pacific Biotechnology market in 2007 was more than US$ 41 Billion. * Japan, China, and Australia are the three largest biotechnology markets in the Asia-Pacific region, with combined market share of around 79% in 2007. The medical biotechnology sector presently accounts for the highest share in the overall market. * Japan remains the largest biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. market in the region; therefore, the country represents a more mature market as compared to other neighbouring markets. * China and India, with low costs and big talent pool, are likely to emerge as the most potential biotech research and manufacturing outsourcing destinations in the future. * Asia-Pacific is expected to become a major destination for stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. research and biogenetic bi·o·gen·e·sis also bi·og·e·ny n. 1. The principle that living organisms develop only from other living organisms and not from nonliving matter. 2. Generation of living organisms from other living organisms. 3. manufacturing. Key Issues and Facts The research report addresses the issues and facts critical to success in the emerging biotechnology industry in Asia-Pacific: * What are the market trends in the Asia-Pacific Biotechnology industry? * An insight into the biotechnology industries of Japan, China, India, South Korea, Australia, Taiwan, New Zealand and Singapore. * An overview of Bioclusters in the Asia-Pacific Biotechnology industry. * Key sectors in the Asia-Pacific Biotechnology industry. * Course of market growth for the next 5 years. * Opportunities that can be leveraged by the Asia-Pacific Biotechnology industry. * Forces that are driving the biotechnology industry in the Asia-Pacific region. * Challenges faced by the Asia-Pacific Biotechnology industry. Research Methodology Information Sources Information has been sourced from various authentic and reliable sources like books, newspapers, trade journals & white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases. Analysis Methods The analysis methods comprise of Ratio Analysis, Historical Trend Analysis, Linear Regression Linear regression A statistical technique for fitting a straight line to a set of data points. Analysis (using software tools), Judgmental judg·men·tal adj. 1. Of, relating to, or dependent on judgment: a judgmental error. 2. Inclined to make judgments, especially moral or personal ones: Forecasting, and Cause and Effect Analysis. Key Topics Covered: 1. Analyst View 2. Global Biotechnology Industry Overview 3. Asia-Pacific Biotechnology Market 4. Asia-Pacific Biotechnology Market by Country 5. Emerging Sectors 6. Roadblocks 7. Future Outlook 8. Competitive Landscape Companies Mentioned: -Invitrogen Corporation -Takara Holdings, Inc. -CSL Limited -Biota Holdings Limited -GlaxoSmithKline Plc For more information visit http://www.researchandmarkets.com/research/65bdec/asia_pacific_biote |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion